HCM registry and DNA/imaging data collection study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of hypertrophic cardiomyopathy (HCM), or a known HCM-causing gene change
- If you’re diagnosed through family history or heart scans, your clinician must meet specific heart-thickness criteria
- If you’re a gene carrier, the genetic test must be for certain sarcomere genes and labeled “pathogenic” or “likely pathogenic” by a certified lab
- You should not have Noonan syndrome or related “Rasopathy” conditions
- You should not have other inherited heart muscle diseases (for example Fabry, Pompe, Danon, or carnitine-related disorders)
- You must be able to consent and upload an echocardiogram and/or cardiac MRI images for review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry (a detailed record) for people with hypertrophic cardiomyopathy, a condition where the heart muscle is thicker than normal. It aims to learn more about the condition over time.
This study tracks people with hypertrophic cardiomyopathy, a heart muscle disease, to learn more about the condition and improve care. It does not test a new treatment but collects health information over time.
This is an observational study (it mainly tracks what happens over time) for people with thickened heart muscle due to hypertrophic cardiomyopathy. You may be eligible if an echocardiogram (heart ultrasound) shows the required thickness and you don’t have certain heart valve disease.
This program builds a registry of people diagnosed with hypertrophic cardiomyopathy and their family members. By collecting health information over time, researchers hope to better understand the condition and improve care.
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
This study builds a patient registry to collect information over time about several types of cardiomyopathy (heart muscle diseases). It may help researchers understand how these conditions progress and what care works best.
Hear when a new Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.